SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form POS AM - Post-Effective amendments for registration statement:
SEC Accession No. 0001193125-23-175153
Filing Date
2023-06-26
Accepted
2023-06-26 16:24:27
Documents
1

Document Format Files

Seq Description Document Type Size
1 POS AM d519636dposam.htm POS AM 32458
  Complete submission text file 0001193125-23-175153.txt   33533
Mailing Address 3101 WESTERN AVENUE SUITE 800 SEATTLE WA 98121
Business Address 3101 WESTERN AVENUE SUITE 800 SEATTLE WA 98121 2062827100
CTI BIOPHARMA CORP (Filer) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: DE | Fiscal Year End: 1231
Type: POS AM | Act: 33 | File No.: 333-33872 | Film No.: 231042656
SIC: 2834 Pharmaceutical Preparations